Login to Your Account



American Heart Association Meeting

ActivBiotics' Rifalazil Misses In Phase III Study In PAD Patients

By Staff Reports


Thursday, November 8, 2007
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription